galactose has been researched along with Arterial Occlusive Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanada, Y; Iwasa, N; Kitamura, E; Mizutani, T; Okazaki, T; Shiraishi, S; Yanagihara, T | 1 |
1 trial(s) available for galactose and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Clinical trials of therapy for sickle cell vaso-occlusive crises. Cooperative urea trials group.
Topics: Alkalies; Anemia, Sickle Cell; Arterial Occlusive Diseases; Bicarbonates; Blood Urea Nitrogen; Evaluation Studies as Topic; Female; Fever; Fructose; Glucose; Hemoglobin C; Hexoses; Humans; Informed Consent; Injections, Intravenous; Male; Pain; Sodium; Solutions; Urea | 1974 |
1 other study(ies) available for galactose and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[Extended voriconazole theraphy and long term survival of a patient with invasive central aspergillosis causing stroke].
Topics: Aged; Antifungal Agents; Antigens, Fungal; Arterial Occlusive Diseases; Aspergillosis; Biomarkers; Carotid Artery, Internal; Central Nervous System Diseases; Diabetes Complications; Diagnostic Imaging; Female; Galactose; Humans; Infusions, Intravenous; Mannans; Paranasal Sinus Diseases; Stroke; Survival; Time Factors; Voriconazole | 2015 |